AXP vs CPHI · P/E 20, rev $41.30B vs rev $4.1M
American Express Company (AXP) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AXP revenue for 2025-12-31 was $41.30B. Net income was $10.83B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the AXP and CPHI stock pages for the full models.
Not investment advice.